How two forms of elinzanetant are processed in healthy women
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman aged 18 to 65
- Be in good overall health
- Weigh at least 50 kg (about 110 lbs) and have a BMI between 18 and 32
- Agree to use effective birth control if you could become pregnant
- Not have taken certain medications or participated in another trial recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.
This study looks at how women use a newer medicine called elinzanetant to manage hot flashes and night sweats from menopause. It's an observational study, meaning you'll continue your regular care while sharing how you're feeling through online surveys.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
This study tests whether fezolinetant, a new medication, can reduce moderate-to-severe hot flashes and night sweats during menopause while protecting heart and brain health. Participants will receive the study drug or placebo and have regular check-ups including brain imaging.
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
Hear when a new Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.